Therapeutic Decision-Making in the Adjuvant Setting in HR+ Breast Cancer - Episode 9

Genomic Assays and Adjuvant Therapy for HR+ Breast Cancer

The value of utilizing a genomic test to help guide decisions for adjuvant therapy for HR-positive breast cancer.